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Abstract: Cone snails produce a fast-acting and often paralyzing venom that is usually injected
into their prey or predator through a hypodermic needle-like modified radula tooth. Many diverse
compounds are found in their venom including small molecules, peptides and enzymes. However,
peptidic toxins called conotoxins (10–40 residues and 2–4 disulfide bonds) largely dominate these
cocktails. These disulfide rich toxins are very valuable pharmacological tools for investigating the
function of ions channels, G-protein coupled receptors, transporters and enzymes. Here, we report
on the synthesis, structure determination and biological activities of two α-conotoxins, CIA and CIB,
found in the predatory venom of the piscivorous species Conus catus. CIA is a typical 3/5 α-conotoxin
that blocks the rat muscle type nAChR with an IC50 of 5.7 nM. Interestingly, CIA also inhibits the
neuronal rat nAChR subtype α3β2 with an IC50 of 2.06 µM. CIB is a 4/7 α-conotoxin that blocks rat
neuronal nAChR subtypes, including α3β2 (IC50 = 128.9 nM) and α7 (IC50 = 1.51 µM). High resolution
NMR structures revealed typical α-conotoxin folds for both peptides. We also investigated the in vivo
effects of these toxins on fish, since both peptides were identified in the predatory venom of C. catus.
Consistent with their pharmacology, CIA was highly paralytic to zebrafish (ED50 = 110 µg/kg),
whereas CIB did not affect the mobility of the fish. In conclusion, CIA likely participates in prey
capture through muscle paralysis, while the putative ecological role of CIB remains to be elucidated.
Keywords: conotoxins; Conus catus; electrophysiology; in vivo; nicotinic receptors; structure; synthesis
Key Contribution: Two new α-conotoxins identified in the injected venom of C. catus have been
synthesized and structurally characterized by NMR. CIB blocks rat neuronal nAChR subtypes,
including α3β2 and α7, whereas CIA potently inhibits the rat muscle type nAChR and was highly
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paralytic to fish. Therefore, CIA likely participates in prey capture through muscle paralysis, while the
putative ecological role of CIB remains to be elucidated.
1. Introduction
Cone snails are predatory marine mollusks comprising more than 800 different species [1].
They capture prey using a venom gland that produces a fast-acting paralyzing venom injected through
a hypodermic needle-like radula tooth [2]. Conotoxins, small (10–40 residues) and highly constrained
peptides (2 to 4 disulfide bridges), are the main components of cone snail venom, which also contains
small molecules and enzymes [3]. Conotoxins are classified into various gene superfamilies based on
their conserved signal sequence. Further classification is based on their cysteine framework and their
target receptor [4,5]. Conotoxins often have highly specific and selective biological activity, and many
of them proved to be very valuable pharmacological tools or even drug leads [6–8]. Indeed their high
selectivity and affinity combined with their small size make these toxins good candidates for the design
of therapeutic peptides or peptide mimetics [9,10]. One particular class of conotoxins, the α-conotoxins,
acts as antagonists of the nicotinic acetylcholine receptors (nAChRs), a diverse family of ligand-gated
ion channels formed by the pentameric assembly of homologous subunits [8].
Both neuronal and muscle type nAChR associated channels open in response to binding of the
neurotransmitter acetylcholine [11], and antagonism of nAChR may be of interest for the treatment of
pain, nicotine addiction or epilepsy [12,13], whereas agonistic action is desired for treating neurological
disorders. The numerous neuronal nAChRs subtypes are involved in a wide variety of biological
mechanisms [14–17] in the central nervous system [14,15] but also in the peripheral nervous system [16]
and the immune system [17]. In the central nervous system, they are involved in neurological disorders
such as Parkinson’s disease, Alzheimer’s disease, epilepsy and schizophrenia [18,19], but also in more
complex mechanisms such as learning, memory or mood control [20]. Whereas some neuronal
subtypes are already validated targets, several combinations of neuronal nAChR subunits remain
orphan of selective ligands and therefore more efforts need to be directed at finding or designing novel
α-conotoxins with tailored pharmacological profiles.
Historically, α-conotoxins have proved to be remarkable probes for characterizing nAChRs
subtypes and establishing their physiological/pathophysiological roles [15,21]. The first α-conotoxins
to be characterized were isolated from Conus geographus venom gland extracts [22]. Their potent
paralytic action at the neuromuscular junction prompted the interpretation of their ecological role
as being essential for prey capture [23]. However, recent findings demonstrated that in the case of
C. geographus, α-conotoxins are injected massively for defense purposes, not for prey capture [2,24].
In order to determine the ecological role of α-conotoxins in other fish-hunting species, we report on
the synthesis, structure determination and biological activities of two new α-conotoxins CIA and CIB
discovered in the venom gland transcriptome and confirmed by proteomic analysis to be present in
the injected predatory venom of the piscivorous species Conus catus [25]. Both CIA and CIB were
investigated at the functional and structural level, as well as tested for in vivo effect on fish.
2. Results
2.1. Chemical Synthesis
Two α-conotoxins, CIA and CIB (Figure 1), were found to be relatively abundant in the predatory
venom of the piscivorous species Conus catus [25]. To determine the biological activity, structure and
ecological role of these conotoxins, both peptides were manually synthesized using Fmoc-based
solid-phase peptide synthesis (see experimental procedures). Assuming the canonical globular
disulfide bond connectivity for α-conotoxins (C1–C3; C2–C4), linear peptides were folded using
a regioselective protection (Acm group) of cysteine residues C1–C3. According to the number of
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residues within the loops, CIA and CIB are 3/5 and 4/7 α-conotoxins and we expected that they would
target muscle type and neuronal type nAChRs, respectively [26–29].Toxins 2018, 10, x FOR PEER REVIEW  3 of 12 
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Figure 1. Sequences of α-conotoxins. (a) Alignment of CIA α-conotoxin with other closely related 3/5
α-conotoxins; (b) Alignment of 4/7 α-conotoxin CIB with MII.
As part of this two-step folding strategy, the standard procedure for the formation of the first
disulfide bond from the two non-protected cysteine residues (C2–C4) typically consists of stirring
the linear peptide in an aqueous basic buffer [30]. However, when the kinetics of disulfide bond
formation are too slow, it is common to add potassium hexacyanoferrate or glutathione and oxidized
glutathione [31] to facilitate the bridge formation [32,33]. Formation of the first disulfide bridge
in an aqueous basic buffer (without any additives) took 24 h to obtain 60% conversion (based on
UV chromatogram) and 40 h to obtain 50% conversion for CIA and CIB respectively. Alternatively,
we found that DTP (2,2′-Dithiopyridine) was very effective in greatly accelerating the disulfide bridge
formation. Surprisingly, this reagent is not widely used, despite its effectiveness being demonstrated
by Maruyama et al. [34] 20 years ago. We used this method on several other conotoxins and to our
experience, if used in a diluted medium, an excess of DTP induces the quasi-total formation of the
intramolecular disulfide bridge in less than 10 min (Figure 2). The second disulfide bond is formed
between C1-C3 after removal of the Acm protecting groups.
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Figure 2. Comparison of disulfide bond formation between free cysteine residues by using air oxidation
or DTP. P stands for usual cysteine lateral chain protective groups.
The ho ogeneity of folded CIA and CIB was assessed by analytical RP-HPLC and MS (Figure 3).
MALDI-MS(+) confirmed a monoisotopic mass of 1614.63 Da (calculated 1614.64 Da for [M + H]+) for
CIA and 1678.65 Da (calculated 1678.64 Da for [M + H] ) for CIB. Overall, 7.7 mg and 3.4 mg of pure
CIA and CIB were obtained, respectively.
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3). MALDI-MS(+) confirmed a monoisotopic mass of 1614.63 Da (calculated 1614.64 Da for [M + H]+) 
for CIA and 1678.65 Da (calculated 1678.64 Da for [M + H]+) for CIB. Overall, 7.7 mg and 3.4 mg of 
pure CIA and CIB were obtained, respectively. 
  
(a) (b) 
Figure 3. HPLC and MS analyses of synthetic CIA and CIB. (a) Synthetic folded CIA UV chromatogram
at 214 nm and mass spectrometry MALDI analysis; (b) Synthetic folded CIB UV chromatogram at
214 nm and mass spectrometry MALDI analysis. Dashed line indicates the acetonitrile gradient.
2.2. Electrophysiology
Next, the biological activity of CIA and CIB was investigated using a two-electrode voltage
clamp analysis on three neuronal nAChRs subtypes (α3β2, α7, α4β2) and the muscle type (α1)2δγβ1
nAChR from rat expressed in Xenopus laevis oocytes. As expected, the 3/5 α-conotoxin CIA potently
blocks the muscle type nAChR with an IC50 of 5.7 nM (Figure 4a). Surprisingly, CIA also inhibits the
neuronal nAChR subtype α3β2, although with >350-fold lower affinity (IC50 of 2.06 µM), whereas no
activity was detected on the two other subtypes at concentration up to 10 µM. In contrast, CIB is a 4/7
α-conotoxin that blocks the neuronal nAChR α3β2 subtype with an IC50 of 128.9 nM and α7 subtype
with an IC50 of 1.51 µM (Figure 4b). No activity was detected on the muscle and α4β2 subtypes at
concentrations up to 10 µM.
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Figure 4. Concentration-response analysis of α-conotoxins CIA (a) and CIB (b) on wild type nAChRs.
The indicated subunit combinations were expressed in Xenopus laevis oocytes and analyzed by
2-electrode voltage clamp at -70 mV. Respo ses to 2-s pulses of 100 µM ACh (or nicotine in case
of the α7 rec ptor) w re recorded after a 3-min preincubation with the indicated toxin. Each point
represents the mean of measurements from at least 3 different oocytes. Error bars represent S.E.M.
2.3. NMR Spectroscopy
High resolution NMR spectroscopy allowed us to determine the three-dimensional structures
of both CIA nd CIB (Figure 5). The structur statistics are given in Tabl 1. The NMR spectra for
CIA indicate the presence of multiple conformations based on the presence of additional cross-peaks,
whereas CIB indicates the presence of a single conformation. The structure determined for CIA was for
the major conformation, as the minor conformation displayed weak peaks. The calculated structures
are well-defined with low RMSDs for residues 5–11. However, CIB has a larger number of NOE
restraints and consequently a better defined structure. CIA has a 310 helix from residues 7–9 and
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CIB an α-helix from residues 6 to 11. CIA has a similar three-dimensional structure to the closely
related peptide, CnIA. Both peptides have a 310 helix involving the Pro7-Ala8-Cys10 sequence (CIA
numbering). The ensembles of CIA and CnIA (PDB code 1B45) superimpose with an RMSD of 1.26 Å
(calculated using MOLMOL). Similarly, CIB is structurally very similar to MII, where both peptides
have a central α-helical region comprising residues 6–11 in CIB and residues 7–11 in MII. The ensembles
of CIB and MII (PDB code 1MII) superimpose with an RMSD of 0.55 Å (calculated using MOLMOL).
The conformational heterogeneity observed for CIA is common to most α-3/5 conotoxins. Indeed,
Favreau et al. reported similar conformational heterogeneity in solution for α-3/5 conotoxin CnIA, but
this also holds true for α-3/5 GI and α-3/5 MI [26,35,36]. This heterogeneity could be due to cis to
trans isomerization of a peptidic bond, but at this stage there is no data to support this hypothesis [26].
The presence of a minor conformation has been identified by Maslennikov et al. for α-conotoxin
GI [35]. These two conformations are interconvertible in solution and differ in the regions of the second
loop and C terminus [35]. Therefore, it is not possible to conclude whether only one or both of the
two conformations is responsible for the activity, or whether each conformation has the same level
of activity.
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Since both CIA and CIB were detected in the predatory venom of the piscivorous C. catus, they 
were injected into fish (Danio rerio) in order to infer the possible ecological role of each conotoxin in 
prey capture. Intramuscular injection of α-conotoxin CIA produces a rapid flaccid paralysis of 
skeletal muscles, as evidenced by a loss of equilibrium of the fish, and ultimately a complete 
immobilization. Paralysis induced by conotoxin α-CIA was a dose-dependent effect, with an IC50 of 
6.88 μM (Figure 6). Based on the calculated average weight of our adult zebrafish (0.5 g) and the 
volume injected (5 μL), CIA has an ED50 of 110 μg/kg. Injection of up to 1 mM of CIB, however, does 
Figure 5. Three-dimensional structures of CIA and CIB. The 20 lowest energy NMR structures,
superimposed over th backbone atoms for CIA (a) and CIB (b). The backbone is shown in ribbon
format and the side-chains in stick format.
Table 1. Structural statistics for CIA and CIB.
CIA CIB
Experimental restraints
Interproton distance r straints 69 98
Intraresidue 30 30
Sequential 28 47
Medium range (i-j < 5) 11 18
Long range (i-j ≥5) 0 3
Disulfide-bond restraints 4 4
Dihedral-angle restraints 21 22
R.m.s deviations from mean coordinate structure (Å)
Backbone atoms 0.95 ± 0.33 0.48 ± 0.16
Backbone atoms (res 5–11) 0.08 ± 0.04 0.19 ± 0.10
All heavy atoms 1.92 ± 0.46 0.95 ± 0.22
All heavy atoms (res 5–11) 0.39 ± 0.41 0.80 ± 0.19
Ramachandran Statistics
Clashscore, all atoms 0 ± 0 0 ± 0
% in most favoured region 85.7 ± 0 91 ± 10
MolProbity score 2.13 ± 0.14 1.68 ± 0.45
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2.4. In vivo Bioassays
Since both CIA and CIB were detected in the predatory venom of the piscivorous C. catus,
they were injected into fish (Danio rerio) in order to infer the possible ecological role of each conotoxin in
prey capture. Intramuscular injection of α-conotoxin CIA produces a rapid flaccid paralysis of skeletal
muscles, as evidenced by a loss of equilibrium of the fish, and ultimately a complete immobilization.
Paralysis induced by conotoxin α-CIA was a dose-dependent effect, with an IC50 of 6.88 µM (Figure 6).
Based on the calculated average weight of our adult zebrafish (0.5 g) and the volume injected (5 µL),
CIA has an ED50 of 110 µg/kg. Injection of up to 1 mM of CIB, however, does not produce any
noticeable effect on the locomotion of zebrafish, which is consistent with the absence of activity on
muscle nAChR.
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Figure 6. Paralytic effect of CIA on zebrafish. Paralysis induced by conotoxin α-CIA shows a
dose-dependent effect, with an IC50 of 6.88 µM.
3. Discussion
Animal venoms are generally complex ixt r of hu dreds or more biologically ctive
compounds. It is assumed that each of these molecules has bee selected thr ugh evolution for
a specific ecological role. Whereas pharmacologically characterized conotoxins from cone snail venom
duct extracts have traditionally been associated to primary roles in prey-capture due to their paralytic
action, recent findings suggest other possible venom-ecology relationships [2]. Indeed, independently
collected predation and defense-evoked venoms unexpectedly showed that the potent paralytic
conotoxins well characterized from C. geographus were almost exclusively injected to defend against
predators, not for prey capture. This is contrary to the consensus literature published on this topic for
the past 30 years. Noteworthy, piscivorous cones of the Gastridium clade such as C. geographus and
C. tulipa employ a r her unusual and unique pr y capture strategy to catch fish, producing an apparent
sedativ effect through p ssive elease of venom compo ents in the surroundin water [2]. On the other
hand, species in the largest clade of fish-hunting cones, namely the Pionoconus, use a “Taser-like” effect
to rapidly stun fish. This effect is thought to be the result of a combination of two synergic conotoxin
types: δ-conotoxins, which inhibit the inactivation of voltage-gated sodium channels, and κ-conotoxins,
which block voltage-dependent potassium channels [37]. However, the predation-evoked venom of
C. striatus and C. consors, two of the largest species of Pionoconus, shows a composition completely
devoid of these conotoxins, composed instead of nearly exclusively unrelated κA-conotoxins, and the
occasional α- and ω-conotoxi s [38,39]. Similarly in the predation-evoked venom of one of the
smallest fish-hunting sp c es, C. catus, Himaya et al. reported mainly the presence of κA-conotoxins,
but consistently also some vertebrate-active and paralytic α-, ω-, an µ-conot xins in significant
amounts [25].
Based on this previous study [25], the sequences corresponding to two major α-conotoxins with
the cysteine pattern CCX3CX5C and CCX4CX7C were synthesized and their biological activity assessed
using electrophysiology and fish bioassays. The first α-conotoxin, named CIA, is a typical muscle type
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α-3/5 conotoxin and its sequence closely resembles those of other α-3/5 conotoxins such as MI, GI and
CnIA. CIA blocks the muscle type nAChR with high affinity (~5 nM), but surprisingly, it was found to
also block the α3β2 neuronal subtype of nAChR, albeit with lower potency (~2 µM). To our knowledge,
CIA is the only known nAChR muscle type α-conotoxin that can also target the neuronal α3β2 subtype
with significant affinity. Whereas the molecular basis for this neuronal nAChR activity remains to be
investigated, conserved proline and tyrosine/phenylalanine residues (corresponding to position 7 and
13 in CIA sequence, respectively) have been shown to be crucial for the strong hydrophobic interaction
between the δ subunit of the muscle type nAChR and conotoxin MI, suggesting a similar mode of
action [27,40] for CIA.
The second α-conotoxin, CIB, blocks the neuronal nAChR α3β2 subtype with an IC50 of 128.9 nM
and the α7 subtype with an IC50 of 1.51 µM. The sequence of CIB is most similar to α-conotoxin MII,
sharing 14 out of 16 amino acids. However, its potency towards α3β2 is approximatively 29-fold lower
compared to MII [41]. The two different residues that most likely account for this difference are proline
in position 13 for CIB instead of a serine for MII and alanine in position 15 for CIB instead of leucine
for MII. By comparing the three-dimensional structures, it appears that the proline residue in position
13 of CIB induces a kink that prevents the alanine in position 15 from filling the hydrophobic pocket in
the same way the leucine does in MII (Figure 7). However, Dutertre et al. [42] using an AChBP model
showed that MII possesses an hydrophobic core (Pro-6, Val-7 and Leu 10) where Pro-6 is involved in a
direct interaction with β2-Leu-119 and additional hydrophobic contacts due to interactions of Val-7
and Leu-10 with β2-Val-109 and β2-Phe-117 respectively. Docking studies would be very helpful to
further investigate how this difference at position 15, which seems to not be directly involved in the
binding with the receptor, can explain the significant loss of activity of CIB compared to MII.
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Conot xins are tradi ionally tested on mam lian system , including human and rodent receptors.
However, in the case of these two α-conotoxins CIA and CIB found in the predatory venom of C. catus,
it was of interest to evaluate their activity on their natural prey (here fish for piscivorous cone snails).
Intramuscular injection of α-conotoxin CIA into fish causes flaccid paralysis of the skeletal muscles
with an effective dose ED50 = 110 µg/kg, highlighting a potent biological effect compatible with a role
in prey capture. At the highest dose (1 mM) tested, the paralysis is almost instantaneous, however
this dose is unlikely to be biologically relevant. Indeed, it was demonstrated for Conus purpurascens
that most conotoxi s expressed in injected venoms range up to 3.51–121.01 µM within a single sting
sample [43]. Therefore, the quas -instantaneous tetanic par lysis provoked by Conus catus sting [44] is
likely due to the most abundant conotoxins injected, namely the κA-conotoxins [25,45]. I deed, Kelley
et al. bserved that the injection of purified κA-conotoxins is able to reproduce the biol gical effects of
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the whole injected venom on fish prey [45]. The role of α-3/5 conotoxins in prey envenomation is most
likely secondary, and the resulting blockade of the neuromuscular junction may prevent the escape
response of a fish prey that would recover from the “Taser-effect” of κA-conotoxins. Interestingly
α-3/5 conotoxin CIA is also found in Conus achatinus and Conus consors [31,46], belonging also to
the Pionoconus clade. On the other hand, injection of α-conotoxin CIB into fish did not cause any
significant change compared to the control. The role of conotoxins targeting neuronal nAChRs in prey
capture remains to be elucidated, but we propose that they may interfere with sensory circuitry and
the escape response of prey.
4. Materials and Methods
4.1. Abbreviations
Acm, acetamidomethyl; ACN, acetonitrile; Boc, tert-butoxycarbonyle; CHCA,
α-Cyano-4-hydroxycinnamic acid; DCM, Dichloromethane; DIEA, diisopropylethylamine;
DMF, N,N′-dimethylformamide; DTP, 2,2′-Dithiopyridine; eq, equivalent; ESI-MS,
electrospray ionization mass spectrometry; Fmoc, fluorenylmethoxycarbonyl; HATU, 1
[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate;
LC/MS, liquid chromatography/mass spectrometry; MALDI, Matrix Assisted Laser
Desorption/Ionization; MeOH, methanol; nAChR, nicotinic acetylcholine receptor; NMR, Nuclear
Magnetic Resonance; Pbf, pentamethyl-dihydrobenzofuran-5-sulfonyl; RP-HPLC, reversed phase
high performance liquid chromatography; SPPS, solid phase peptide synthesis; t-Bu, tert-butyl;
TFA, trifluoroacetic acid; TIS, triisopropylsilane; Tris, 2-Amino-2-(hydroxymethyl)propane-1,3-diol;
Trt, trityl; UV, ultra-violet.
4.2. Chemical Synthesis
DMF, DIEA, ACN, TIS, TFA, piperidine and all others reagents were obtained from Sigma-Aldrich
(Saint-Louis, MI, USA) or Merck (Darmstadt, Allemagne) and were used as supplied. Fmoc (L)
amino acid derivatives and HATU were purchased from Iris Biotech (Marktredwitz, Germany).
AmphiSpheres 40 RAM resin (0.37 mmol/g 75–150 µm) was purchased from Agilent Technologies
(Les Ulis, France). The side chain protecting groups for amino acids are t-Bu for Asp, Glu, Ser, Thr
and Tyr; Trt for Cys3,16 of CIB and Cys5,15 of CIA, Acm for Cys2,8 of CIB and Cys4,9 of CIA; Trt for Gln;
Pbf for Arg; Boc for Lys and Trp. CIA and CIB were manually synthesized by using the Fmoc-based
solid-phase peptide synthesis technique on a VWR (Radnor, PA, USA) microplate shaker. All Fmoc
amino acids and HATU were dissolved in DMF to reach 0.5 M. Chain elongation was performed step
by step using 0.1 mmol of AmphiSpheres 40 RAM resin. Fmoc deprotection was performed with 20%
piperidine in DMF two times, each for 1 min at room temperature, then the resin is washed three times
with DMF. Each Fmoc-protected amino acid (5 eq) was coupled in the presence of HATU (5 eq) and
N,N-diisopropylethylamine (DIEA, 10 eq) in DMF at room temperature for two min. After completion
of coupling reaction, the resin was sequentially washed two times with DMF. Cleavage of peptide
from the resin and removal of side-chain protecting groups were carried out using 10 mL of a solution
containing TFA/TIS/H2O (95:2.5:2.5, v/v/v) for 15 min at 60 ◦C. After the resin was removed by
filtration and washed three times with dichloromethane. Dichloromethane and TFA are removed under
vacuum then cold diethyl ether was added to precipitate the peptide. Crude peptides were purified by
preparative RP-HPLC, and their purity were confirmed by LC/ESI-MS. A twostep oxidation procedure
was then carried out. Trt groups were removed during the cleavage step while the Acm protective
groups are resistant to cleavage conditions. The first disulfide bridge is formed from free cysteines with
the use of DTP and the second disulfide bridge is formed by concomitant deprotection and oxidation
of the Acm groups [30,34].
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4.3. Mass Spectrometry
Solvents used for LC/MS were of HPLC grade. The LC/MS system consisted of a Waters
(Milford, OH, USA) Alliance 2695 HPLC, coupled to a Waters Micromass ZQ spectrometer (electrospray
ionization mode, ESI+). All the analyses were carried out using a Chromolith (Fontenay sous Bois,
France) HighResolution RP-18e (4.6 × 25 mm, 15 nm–1.15 µm particle size, flow rate 3.0 mL/min)
column. A flow rate of 3 mL/min and a gradient of 0–100% B over 2.5 min were used. Eluent A:
water/0.1% HCO2H; eluent B: acetonitrile/0.1% HCO2H. UV detection was performed at 214 nm.
Electrospray mass spectra were acquired at a solvent flow rate of 200 µL/min. Nitrogen was used
for both the nebulizing and drying gas. The data were obtained in a scan mode ranging from 100 to
1000 m/z or 250 to 1500 m/z to in 0.7 s intervals. MALDI mass spectrometry analyses were performed
on an Ultraflex III instrument from Bruker Daltonics (Champs sur Marne, France). Each sample was
analyzed from CHCA matrix deposit in positive-ion mode.
4.4. Preparative RP-HPLC
Preparative RP-HPLC was run on a Gilson PLC 2250 Purification system (Villiers le Bel, France)
instrument using a preparative column (Waters DeltaPak C18 Radial-Pak Cartridge, 100 Å, 40 × 100
mm, 15 µm particle size, flow rate 50.0 mL/min). Buffer A was 0.1% TFA in water, and buffer B was
0.1% TFA in acetonitrile.
4.5. Electrophysiology Measurements
cDNAs of rat nAChR subunits used in this study were provided by J. Patrick (Baylor College of
Medicine, Houston, TX, USA) and subcloned into the oocyte expression vector pNKS2. cRNA was
synthesized with the SP6 mMessage mMachine Kit (Ambion, Austin, TX, USA) and adjusted to a
concentration of 0.5 mg/mL. nAChR subunit RNAs were mixed in the ratios 1:1 (α3/β2), 5:1 (α4/β2),
and 2:1:1:1 (α1/β1/δ/γ). Xenopus laevis (Nasco International, Fort Atkinson, WI, USA) oocytes were
injected with 50 nl aliquots of cRNA (Nanoject automatic oocyte injector, Drummond Scientific,
Broomall, PA). Antagonist dose-response curves were measured as described previously (Dutertre
et al., 2005) in ND96 (96 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES at pH
7.4). In brief, current responses to acetylcholine were measured 1–6 days after cRNA injection and
recorded at−70 mV using a Turbo Tec 05X Amplifier (NPI Electronic, Tamm, Germany) and Cell Works
software. A standard concentration of 100 µM ACh for α3β2, α4β2 nAChRs and (α1)2δγβ muscle
nAChR and a standard concentration of 100 µM nicotine for the α7 nAChR was used to keep the data
comparable to previous studies. A fast and reproducible solution exchange (<300 ms) was achieved
with a 50-µL funnel-shaped oocyte chamber combined with a fast vertical solution flow fed through a
custom-made manifold mounted immediately above the oocyte. Agonist pulses were applied for 2 s
at 4-min intervals. Following one minute of perfusion directly after the agonist application, peptides
were applied in a static bath for 3 min. IC50 values were calculated from a nonlinear fit of the Hill
equation to the data (Prism version 4.0; GraphPad Software, Inc., San Diego, CA). Data are presented
as means ± S.E.M. from at least three oocytes.
4.6. NMR Spectroscopy
Lyophilized synthetic peptides were resuspended to a final concentration of ~2.5 mM in
90%H2O:10%D2O. 2D 1H-1H TOCSY, 1H-1H NOESY, 1H-1H DQF-COSY, 1H-15N HSQC, and 1H-13C
HSQC spectra were acquired at 290 K using a 600 MHz AVANCE III NMR spectrometer (Bruker,
Karlsruhe, Germany) equipped with a cryogenically cooled probe. All spectra were recorded with an
interscan delay of 1 s. NOESY spectra were acquired with mixing times of 200–250 ms, and TOCSY
spectra were acquired with isotropic mixing periods of 80 ms. Two-dimensional spectra were collected
over 4096 data points in the f2 dimension and 512 increments in the f1 dimension over a spectral
width of 12 ppm. Standard Bruker pulse sequences were used with an excitation sculpting scheme
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for solvent suppression. Slowly exchanging amide protons were detected by acquiring a series of
one-dimensional and TOCSY spectra over a 24 h period, following dissolution of the peptides in D2O.
The two-dimensional NOESY spectra of CIA and CIB were automatically assigned and an ensemble of
structures calculated using the program CYANA [47]. Torsion-angle restraints from TALOS+ were
used in the structure calculations. Distance restraints between the beta carbons and sulfur atoms of the
cysteine residues that are disulfide bonded were included in the structure calculations. Restraints were
included between Cys I-Cys II and Cys II-Cys IV. The final structures were visualized using Pymol.
4.7. In vivo Bioassay
Zebrafish were maintained under standardized conditions and experiments were conducted
in accordance with the European Communities council directive 2010/63. Briefly, CIA and CIB
were diluted in milli-Q water and 5 µL of incremental doses were injected intramuscularly into adult
zebrafish with a 10 µL Neuros Syringe from Hamilton (Bonaduz, Switzerland). Each dose was repeated
three times on three different fishes to determine error bars. The onset of paralysis was measured over
a maximum observation time of 10 min. Paralysis was considered total when the fish went on its back.
We performed negative control experiments according to the same protocol by injecting milli-Q water
instead of toxins.
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